Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial.
about
HIV, sexual violence and special populations: adolescence and pregnancyLactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli.HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificitiesBacterial vaginosis and the cervicovaginal immune response.The barrier to HIV transmission provided by genital tract Lactobacillus colonization.Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in womenSoluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition.Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.The Role of Defensins in HIV Pathogenesis.Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women.The Vaginal Microenvironment: The Physiologic Role of Lactobacilli.
P2860
Q26825943-3DC6B6D6-6C66-4E52-831E-D1733A3EA0AAQ33578080-3412B9CB-2432-42CC-9250-5AFA8BB92D13Q33939974-E3F577FD-7E7E-432C-B6AC-C210E01FBEB4Q34027489-876EA3CC-E5C7-4656-8711-BA60A6263560Q35128826-ACE1D1F4-4B4F-45B9-A5C2-9A754D4E8252Q35136930-C87B6373-2C19-4031-BEB2-A655AF763256Q36068677-427971E6-FCF8-439C-B38E-6E7D76F6CB37Q36068904-5C6559AD-AFB3-4E77-973B-897A03CE8B5DQ36294689-B3A5DED3-9D58-4783-AD5F-879DBC3D4BF2Q36471518-B9848A11-8DD8-4EEE-BC8A-1ADA212D9F98Q38637503-16565367-CE81-44A2-897C-5E8CEF9247BDQ40248406-F78C03BA-91CE-4764-94A1-821B541AC13BQ55408374-2B17C959-F803-4D53-9618-B19DCD711BFB
P2860
Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mucosal Escherichia coli bacte ...... ipating in the HPTN 035 trial.
@ast
Mucosal Escherichia coli bacte ...... ipating in the HPTN 035 trial.
@en
type
label
Mucosal Escherichia coli bacte ...... ipating in the HPTN 035 trial.
@ast
Mucosal Escherichia coli bacte ...... ipating in the HPTN 035 trial.
@en
prefLabel
Mucosal Escherichia coli bacte ...... ipating in the HPTN 035 trial.
@ast
Mucosal Escherichia coli bacte ...... ipating in the HPTN 035 trial.
@en
P2093
P2860
P50
P356
P1476
Mucosal Escherichia coli bacte ...... ipating in the HPTN 035 trial.
@en
P2093
Barbra A Richardson
Betsy C Herold
HPTN 035 Protocol Team
Jessica Tugetman
MTN Biomedical Sciences Working Group
Sharon L Hillier
P2860
P304
P356
10.1093/INFDIS/JIS555
P407
P50
P577
2012-09-10T00:00:00Z